Page 10 - Astrazeneca

US puts J&J in charge of plant that botched vaccine, removes AstraZeneca

US puts J&J in charge of plant that botched vaccine, removes AstraZeneca

Coronavirus: Seven blood clot deaths in UK after taking AstraZeneca jab

The MHRA previously said there had been 30 cases of rare blood clot events reported out of the 18.1 million AstraZeneca/Oxford vaccine doses administered in Britain

Britain sees 25 new blood-clot cases linked to AstraZeneca vaccine

The country's drugs regulator said the benefits of the shot continue to outweigh the risks

Sri Lanka temporarily halts Covid jabs on delay in procurement from Serum

Sri Lanka has temporarily halted its Covid-19 vaccination programme as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India, a top health minister has said

India indefinitely puts on hold AstraZeneca's vaccine shipment to Canada

Shipments of the coronavirus vaccine from the Serum Institute to Canada have been put on hold for an indefinite period as India has temporarily stopped vaccine exports so as to cater to domestic needs

AstraZeneca delivered 29.8 million Covid vaccine doses to European Union

AstraZeneca has delivered 29.8 million doses of its Covid-19 vaccine to European Union (EU) member states in the first quarter (Q1) of 2021, just "a few doses away" from the promised 30 million

Supply chain threats

Vaccine nationalism shows how the pandemic has stressed trade

DCGI extends shelf life of Covishield Covid-19 vaccine from 6 to 9 months

India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca Covid-19 vaccine, from six to nine months from its manufacturing date

AstraZeneca shots halted in parts of Germany for under-60s over clot risk

Several health authorities in Germany said they are again suspending the use of AstraZeneca's vaccine for residents under age 60 amid fresh reports of unusual blood clots

Italy PM Mario Draghi receives AstraZeneca's coronavirus vaccine jab

Italy's Prime Minister Mario Draghi received his first dose of AstraZeneca's coronavirus vaccine -- the same product that his government had decided to temporarily halt the use of earlier this month

Canada halts AstraZeneca's coronavirus vaccine for adults under 55 years

Canada's National Advisory Committee on Immunization (NACI) has recommended that the AstraZeneca Covid-19 vaccine should not be used in adults under 55 years of age at this time

India extends shelf life of Serum's Covishield to 9 months: Report

The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities minimise vaccine wastage

Germany to discuss AstraZeneca Covid-19 shots after blood clot reports

Health Minister Jens Spahn will talk with his regional counterparts at 1800 CET (1600 GMT), a ministry spokesman said

Finland resumes use of AstraZeneca's Covid vaccine for people above 65 yrs

Finland has resumed the use of the AstraZeneca Covid-19 vaccine, but only for people over the age of 65, as per the guidelines issued by the Finnish Institute for Health and Welfare

Canadian panel recommends AstraZeneca vaccine pause for under 55

Canada's National Advisory Committee on Immunisation is recommending a pause on AstraZeneca COVID-19 vaccinations for people under 55 for safety reasons

Coronavirus vaccine: Germany reports more AstraZeneca clot cases

Germany's medical regulator says it has received reports of 21 cases of rare blood clots in people who had recently received AstraZeneca's coronavirus vaccine.

Top headlines: SC 'unseats' minority shareholders; vax makers seek govt aid

The price of the AstraZeneca vaccine - the one sold the most globally- varies from $2 to $6 per dose. India has got this vaccine at $2.06 per dose, the cheapest in the world. Read today's top news

At $2.06 per dose, India pays the least for AstraZeneca Covid-19 vaccine

The price paid by different governments for a vaccine dose - including for the same vaccine - varies across countries, Unicef data shows

SII, Bharat Bio seek central fund injection to ramp up vaccine production

SII, Bharat Biotech want to increase production to meet domestic, foreign demand

AstraZeneca updates Covid-19 vaccine efficacy rate to 76%

AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major U.S. trial